We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GLTO

Price
3.37
Stock movement up
+0.00 (0.00%)
Company name
Galecto Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
4.48M
Ent value
-12.76M
Price/Sales
3.72
Price/Book
0.21
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-75.85%
3 year return
-60.23%
5 year return
-
10 year return
-
Last updated: 2025-09-12

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

GLTO does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.72
Price to Book0.21
EV to Sales-10.62

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count1.32M
EPS (TTM)-18.49
FCF per share (TTM)-21.98

Income statement

Loading...
Income statement data
Revenue (TTM)1.20M
Gross profit (TTM)738.00K
Operating income (TTM)-20.14M
Net income (TTM)-21.17M
EPS (TTM)-18.49
EPS (1y forward)-2.94

Margins

Loading...
Margins data
Gross margin (TTM)61.40%
Operating margin (TTM)-1675.62%
Profit margin (TTM)-1761.48%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash19.68M
Net receivables1.21M
Total current assets21.18M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets23.38M
Accounts payable503.00K
Short/Current long term debt32.00K
Total current liabilities2.44M
Total liabilities2.44M
Shareholder's equity20.93M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-25.16M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-25.16M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-101.14%
Return on Assets-90.58%
Return on Invested Capital-100.98%
Cash Return on Invested Capital-120.00%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.33
Daily high3.38
Daily low3.28
Daily Volume7K
All-time high421.00
1y analyst estimate6.00
Beta1.35
EPS (TTM)-18.49
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
GLTOS&P500
Current price drop from All-time high-99.20%-1.46%
Highest price drop-99.47%-56.47%
Date of highest drop10 Apr 20259 Mar 2009
Avg drop from high-84.26%-10.99%
Avg time to new high121 days12 days
Max time to new high1191 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
GLTO (Galecto Inc) company logo
Marketcap
4.48M
Marketcap category
Small-cap
Description
Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Employees
5
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...